tiprankstipranks
AEON Biopharma Announces Warrant Exercise Deadline and Terms
Company Announcements

AEON Biopharma Announces Warrant Exercise Deadline and Terms

Don't Miss our Black Friday Offers:

AEON Biopharma (AEON) has provided an announcement.

AEON Biopharma, Inc. has notified holders of its public warrants that they must exercise their right to purchase shares of the company’s common stock by April 29, 2024, or the warrants will become void. The fair market value for redemption has been set at $7.6994 per share, and on a cashless basis, holders will receive approximately 0.2456 shares for each warrant exercised. Unexercised warrants after the deadline will only entitle holders to a redemption price of $0.10 per warrant.

For a thorough assessment of AEON stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAEON Biopharma Releases New Investor Presentation
TheFlyAeon Biopharma announces outcome from FDA biosimilar advisory meeting
TheFlyAeon Biopharma files $200M mixed securities shelf
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App